NCT02966041View on ClinicalTrials.gov

Prophylactic Ondansetron in Post-op Cardiac Surgery Patients to Prevent Post-operative Nausea and Vomiting

NACompletedINTERVENTIONAL

Enrollment

186

Participants

Timeline

Start Date

March 6, 2018

Primary Completion Date

July 11, 2018

Study Completion Date

July 11, 2018

Conditions

Postoperative Nausea and Vomiting

Interventions

DRUG

Ondansetron

Ondansetron/Zofran is an antiemetic drug used to prevent and treat nausea and vomiting.

DRUG

Saline

Normal saline is salt water and is acting as a placebo in this study. A placebo is an inactive substance that looks identical to the test drug, but it contains no therapeutic ingredient.

Trial Locations (1)

V6Z 1Y6

St. Paul's Hospital, Vancouver

All Listed Sponsors

lead

University of British Columbia

OTHER

NCT02966041 - Prophylactic Ondansetron in Post-op Cardiac Surgery Patients to Prevent Post-operative Nausea and Vomiting | Biotech Hunter | Biotech Hunter